Global ICAD Intracranial Atherosclerotic Disease Pathology Market Research Report 2023(Status and Outlook)

Global ICAD Intracranial Atherosclerotic Disease Pathology Market Research Report 2023(Status and Outlook)



Report Overview

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.

Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.

The Global ICAD Intracranial Atherosclerotic Disease Pathology Market Size was estimated at USD 161.00 million in 2022 and is projected to reach USD 290.55 million by 2029, exhibiting a CAGR of 8.80% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global ICAD Intracranial Atherosclerotic Disease Pathology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global ICAD Intracranial Atherosclerotic Disease Pathology Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the ICAD Intracranial Atherosclerotic Disease Pathology market in any manner.

Global ICAD Intracranial Atherosclerotic Disease Pathology Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Stryker

Balt

TERUMO

MicroPort

Acandis

Market Segmentation (by Type)

Stent

PTA Balloon

Market Segmentation (by Application)

Ceramics

Polymers

Paints

Metallurgy

Friction Products

Construction

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the ICAD Intracranial Atherosclerotic Disease Pathology Market

Overview of the regional outlook of the ICAD Intracranial Atherosclerotic Disease Pathology Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of ICAD Intracranial Atherosclerotic Disease Pathology
1.2 Key Market Segments
1.2.1 ICAD Intracranial Atherosclerotic Disease Pathology Segment by Type
1.2.2 ICAD Intracranial Atherosclerotic Disease Pathology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ICAD Intracranial Atherosclerotic Disease Pathology Market Overview
2.1 Global Market Overview
2.1.1 Global ICAD Intracranial Atherosclerotic Disease Pathology Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global ICAD Intracranial Atherosclerotic Disease Pathology Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ICAD Intracranial Atherosclerotic Disease Pathology Market Competitive Landscape
3.1 Global ICAD Intracranial Atherosclerotic Disease Pathology Sales by Manufacturers (2018-2023)
3.2 Global ICAD Intracranial Atherosclerotic Disease Pathology Revenue Market Share by Manufacturers (2018-2023)
3.3 ICAD Intracranial Atherosclerotic Disease Pathology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global ICAD Intracranial Atherosclerotic Disease Pathology Average Price by Manufacturers (2018-2023)
3.5 Manufacturers ICAD Intracranial Atherosclerotic Disease Pathology Sales Sites, Area Served, Product Type
3.6 ICAD Intracranial Atherosclerotic Disease Pathology Market Competitive Situation and Trends
3.6.1 ICAD Intracranial Atherosclerotic Disease Pathology Market Concentration Rate
3.6.2 Global 5 and 10 Largest ICAD Intracranial Atherosclerotic Disease Pathology Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ICAD Intracranial Atherosclerotic Disease Pathology Industry Chain Analysis
4.1 ICAD Intracranial Atherosclerotic Disease Pathology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of ICAD Intracranial Atherosclerotic Disease Pathology Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ICAD Intracranial Atherosclerotic Disease Pathology Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global ICAD Intracranial Atherosclerotic Disease Pathology Sales Market Share by Type (2018-2023)
6.3 Global ICAD Intracranial Atherosclerotic Disease Pathology Market Size Market Share by Type (2018-2023)
6.4 Global ICAD Intracranial Atherosclerotic Disease Pathology Price by Type (2018-2023)
7 ICAD Intracranial Atherosclerotic Disease Pathology Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global ICAD Intracranial Atherosclerotic Disease Pathology Market Sales by Application (2018-2023)
7.3 Global ICAD Intracranial Atherosclerotic Disease Pathology Market Size (M USD) by Application (2018-2023)
7.4 Global ICAD Intracranial Atherosclerotic Disease Pathology Sales Growth Rate by Application (2018-2023)
8 ICAD Intracranial Atherosclerotic Disease Pathology Market Segmentation by Region
8.1 Global ICAD Intracranial Atherosclerotic Disease Pathology Sales by Region
8.1.1 Global ICAD Intracranial Atherosclerotic Disease Pathology Sales by Region
8.1.2 Global ICAD Intracranial Atherosclerotic Disease Pathology Sales Market Share by Region
8.2 North America
8.2.1 North America ICAD Intracranial Atherosclerotic Disease Pathology Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe ICAD Intracranial Atherosclerotic Disease Pathology Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific ICAD Intracranial Atherosclerotic Disease Pathology Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America ICAD Intracranial Atherosclerotic Disease Pathology Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa ICAD Intracranial Atherosclerotic Disease Pathology Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Stryker
9.1.1 Stryker ICAD Intracranial Atherosclerotic Disease Pathology Basic Information
9.1.2 Stryker ICAD Intracranial Atherosclerotic Disease Pathology Product Overview
9.1.3 Stryker ICAD Intracranial Atherosclerotic Disease Pathology Product Market Performance
9.1.4 Stryker Business Overview
9.1.5 Stryker ICAD Intracranial Atherosclerotic Disease Pathology SWOT Analysis
9.1.6 Stryker Recent Developments
9.2 Balt
9.2.1 Balt ICAD Intracranial Atherosclerotic Disease Pathology Basic Information
9.2.2 Balt ICAD Intracranial Atherosclerotic Disease Pathology Product Overview
9.2.3 Balt ICAD Intracranial Atherosclerotic Disease Pathology Product Market Performance
9.2.4 Balt Business Overview
9.2.5 Balt ICAD Intracranial Atherosclerotic Disease Pathology SWOT Analysis
9.2.6 Balt Recent Developments
9.3 TERUMO
9.3.1 TERUMO ICAD Intracranial Atherosclerotic Disease Pathology Basic Information
9.3.2 TERUMO ICAD Intracranial Atherosclerotic Disease Pathology Product Overview
9.3.3 TERUMO ICAD Intracranial Atherosclerotic Disease Pathology Product Market Performance
9.3.4 TERUMO Business Overview
9.3.5 TERUMO ICAD Intracranial Atherosclerotic Disease Pathology SWOT Analysis
9.3.6 TERUMO Recent Developments
9.4 MicroPort
9.4.1 MicroPort ICAD Intracranial Atherosclerotic Disease Pathology Basic Information
9.4.2 MicroPort ICAD Intracranial Atherosclerotic Disease Pathology Product Overview
9.4.3 MicroPort ICAD Intracranial Atherosclerotic Disease Pathology Product Market Performance
9.4.4 MicroPort Business Overview
9.4.5 MicroPort ICAD Intracranial Atherosclerotic Disease Pathology SWOT Analysis
9.4.6 MicroPort Recent Developments
9.5 Acandis
9.5.1 Acandis ICAD Intracranial Atherosclerotic Disease Pathology Basic Information
9.5.2 Acandis ICAD Intracranial Atherosclerotic Disease Pathology Product Overview
9.5.3 Acandis ICAD Intracranial Atherosclerotic Disease Pathology Product Market Performance
9.5.4 Acandis Business Overview
9.5.5 Acandis ICAD Intracranial Atherosclerotic Disease Pathology SWOT Analysis
9.5.6 Acandis Recent Developments
10 ICAD Intracranial Atherosclerotic Disease Pathology Market Forecast by Region
10.1 Global ICAD Intracranial Atherosclerotic Disease Pathology Market Size Forecast
10.2 Global ICAD Intracranial Atherosclerotic Disease Pathology Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe ICAD Intracranial Atherosclerotic Disease Pathology Market Size Forecast by Country
10.2.3 Asia Pacific ICAD Intracranial Atherosclerotic Disease Pathology Market Size Forecast by Region
10.2.4 South America ICAD Intracranial Atherosclerotic Disease Pathology Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of ICAD Intracranial Atherosclerotic Disease Pathology by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global ICAD Intracranial Atherosclerotic Disease Pathology Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of ICAD Intracranial Atherosclerotic Disease Pathology by Type (2024-2029)
11.1.2 Global ICAD Intracranial Atherosclerotic Disease Pathology Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of ICAD Intracranial Atherosclerotic Disease Pathology by Type (2024-2029)
11.2 Global ICAD Intracranial Atherosclerotic Disease Pathology Market Forecast by Application (2024-2029)
11.2.1 Global ICAD Intracranial Atherosclerotic Disease Pathology Sales (K Units) Forecast by Application
11.2.2 Global ICAD Intracranial Atherosclerotic Disease Pathology Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings